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Isovaleric acidemia, an inborn error of leucine metabolism, has been
characterized by a marked accumulation of isovaleric acid in serum and
an increased urinary excretion of N .isovalerylglycine, and the genetic
defect has been suggested to be at the level of isovaleryl CoA dehydro.
genase 0, 2, 3).
On the one hand, the following facts have been found in Okayama.
When isovaleric acid is administered to some normal animals, isovalthine
(4) is excreted in their urine (5, 6). However, when isovaleric acid·I.CH
or ·4_C14 is administered to some animals, isovalthine excreted has never
been labeled (7,8,9).
In these circumstances, it is quite interesting to know whether the
patient with isovaleric acidemia excretes isovalthine or not.
The urine samples of the patients tested are shown in Table I. The
urine samples of each patient were combined separately and each sample
(B. A.: 379 ml; S. A.: 275 ml) was made weakly acidic (around pH 5)
with dilute hydrochloric acid and filtered. The filtrate was transferred on
a column containing 100 ml of Diaion SK-l (H-form of sulfonated cation
Table 1. Urine Samples of the Patients Tested.
---- -----------------------------------------
Patients
B.A.
3 1/2 years old
S.A.
5 1/4 years old
Clinical
State
Coma
Lethargy
Remission
Remission
Remission
Remission
24 Hour Urine
Volume
(ml)
940
760
116
1816
625
615
160
1400
107
Volume of Urine
Used for Analysis
(ml)
80
260
39
379
100
85
90
275
Dried
Residue
(gm)
0.6
2.0
1.5
4.1
2.0
0.7
0.4
3.1
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exchanger, mesh 100, Mitsubishi Kasei Co., Tokyo) and the column was
washed with II of water. The effluent and washing were combined and
evaporated to dryness under reduced pressure (Fraction IV). The column
was then eluted with 800 ml of 2N-NHs and the ammonia eluate was dried
under reduced pressure. The dried residue was dissolved in 100 ml of O. 2M
acetic acid and filtered. The filtrate was transferred on a column con-
taining 50 ml of Amberlite CG-4B (acetate form, mesh 100-200) and the
column was washed with 500 ml of O. 2M acetic acid. The effluent and
washing were combined and dried (Fraction I). The Amberlite column
was then washed with each 500 ml of 2M acetic acid and 2N-HCl succes-
sively. The 2M acetic acid eluate (Fraction II) and 2 N-HCl (Fraction
III) were dried separately.
Fraction IV was hydrolyzed in 6N.HCl for 12 hrs, and the hydrolysate
was dried, dissolved in 100 ml of water, and filtered. The free amino
acids in the filtrate was collected by using Diaion SK-l column as des-
cribed above.
Fraction I contains mainly NH2-free basic and neutral, Fraction II
acidic, Fraction III strong acidic amino acids and peptides. Fraction IV
is the hydrolysate of NH 2-covered amino acids and peptides. Isovalthine is
usually found in Fraction II. In this experiment, however, all fractions
of both samples were analyzed before and after hydrolysis on an automatic
amino acid analyzer (Beckman Model 120-B, 150 em column, 0.2M Na
citrate buffer of pH 3.24 at 30°)1° and by two dimensional paper electro-
phoresis. 11 The minimum quantity of isovalthine determined accurately
by our amino acid analyzer is O. 1 p. mole and detected by paper electro.
phoresis 0.01 p. mole. As the results of these analyses, isovalthine was not
found in any of the fractions tested.
Judging from our studies on experimental isovalthinuria, (5, 6) the
serum isovaleric acid level of the patients, especially in the state of acido-
sis, (1) seems to be sufficient for the induction of isovalthinuria. Never-
theless, isovalthine was not detected even in the urine of an acidotic
patient (E. A,)
The following considerations should be taken into account for the
present result.
(1) The volume of urine tested might be too little to detect isoval.
thine. But 200 ml of urine was enough to estimate the isovalthine quantity
in the studies on experimental isovalthinuria (5, 6, 12, 13).
(2) Isobutyric acid and some other lower fatty acids were known to
disturb the isovalthinuria inducing effect of isovaleric acid (5). So the high
content of isobutyric acid etc. in the serum of the patients 1 might have
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disturbed the isovalthine formation.
(3) Isovaleric acid is further metabolized in the normal animals, but
not in the isovaleric acidemics. So some metabolic changes of isovaleric
acid in the animal body might be necessary for the induction of isoval.
thinuria. The fact that isovaleric acid-l-C I4 or-4-C14 administered to some
normal animals never incorporated into urinary isovalthine (7, 8, 9) might
allow this assumption.
The mechanism of induction of isovalthinuria and the direct precursor
of isovaleric acid residue in the isovalthine molecule are still unknown.
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